Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.28 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vistagen Therapeutics (VTGN) Cash from Investing Activities (2010 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Cash from Investing Activities of -$99,000 for fiscal Q4 2026 (quarter ended Mar 31, 2026), compared with $527,000 a year earlier.

Analysis

Vistagen Therapeutics (VTGN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Cash from Investing Activities came in at -$877,000.

  • In prior fiscal years, Vistagen Therapeutics' Cash from Investing Activities was -$13.15 million in FY2025, -$61,000 in FY2024, -$740,000 in FY2023 and -$200,400 in FY2022.
  • Quarterly Cash from Investing Activities has run from a low of -$7.79 million in fiscal Q2 2025 to a high of $527,000 in fiscal Q4 2025 over five years.
  • According to Business Quant data, Cash from Investing Activities for the three prior fiscal quarters was $104,000 (Q3 2026), -$94,000 (Q2 2026) and -$788,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Vistagen Therapeutics 12.43 Mn 12.43 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -99,000.00
Dec 31, 2025 104,000.00
Sep 30, 2025 -94,000.00
Jun 30, 2025 -788,000.00
Mar 31, 2025 527,000.00
Dec 31, 2024 -422,000.00
Sep 30, 2024 -7.79 Mn
Jun 30, 2024 -5.47 Mn
Mar 31, 2024 -29,000.00
Dec 31, 2023 -32,000.00
Mar 31, 2023 -528,000.00
Dec 31, 2022 -12,500.00
Sep 30, 2022 -24,400.00
Jun 30, 2022 -175,100.00
Mar 31, 2022 -100.00
Dec 31, 2021 100.00
Sep 30, 2021 -50,500.00
Jun 30, 2021 -149,900.00
Mar 31, 2021 -25,500.00
Dec 31, 2020 -151,100.00
API Access

Vistagen Therapeutics Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=VTGN&period=max&api_key=YOUR_API_KEY